艾美疫苗(06660)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06660 艾美疫苗

未开盘 03-13 16:08:50

3.640

-0.240

-6.19%

最高3.940	最低3.600	成交量276.20万
今开3.900	昨收3.880	日振幅8.76%
总市值44.66亿	流通市值18.49亿	总股本12.27亿
成交额1,012万	换手率0.54%	流通股本5.08亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06660","market":"HK","secType":"STK","nameCN":"艾美疫苗","latestPrice":3.64,"timestamp":1741853330019,"preClose":3.88,"halted":0,"volume":2762000,"delay":0,"floatShares":508000000,"shares":1227000000,"eps":-1.1522121373414573,"marketStatus":"未开盘","change":-0.24,"latestTime":"03-13 16:08:50","open":3.9,"high":3.94,"low":3.6,"amount":10121200,"amplitude":0.087629,"askPrice":3.65,"askSize":1000,"bidPrice":3.64,"bidSize":36600,"shortable":3,"etf":0,"ttmEps":-1.053805071313106,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1741915800000},"marketStatusCode":0,"adr":0,"listingDate":1664985600000,"exchange":"SEHK","adjPreClose":3.88,"openAndCloseTimeList":[[1741829400000,1741838400000],[1741842000000,1741852800000]],"volumeRatio":0.293029,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06660","defaultTab":"news","newsList":[{"id":"2518758410","title":"艾美疫苗盘中异动 股价大跌5.12%报3.890港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518758410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518758410?lang=zh_cn&edition=full","pubTime":"2025-03-11 10:31","pubTimestamp":1741660302,"startTime":"0","endTime":"0","summary":"2025年03月11日早盘10时31分，艾美疫苗股票出现波动，股价急速下挫5.12%。艾美疫苗股票所在的药品行业中，整体涨幅为0.12%。值得注意，艾美疫苗当前业绩并不理想，自2021年起，公司营收增速放缓，业绩出现大幅亏损。目前，艾美疫苗的收入主要来源于其核心产品乙肝疫苗和狂犬病疫苗，其中狂犬病疫苗收入占比近六成。另外，复星国际证券在研报中指出，艾美疫苗的13价肺炎疫苗和23价肺炎疫苗预计分别为2025年和2026年获批。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031110314398a341a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031110314398a341a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2518509152","title":"艾美疫苗三年亏损超23亿，高端疫苗如何突围？","url":"https://stock-news.laohu8.com/highlight/detail?id=2518509152","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518509152?lang=zh_cn&edition=full","pubTime":"2025-03-10 10:51","pubTimestamp":1741575102,"startTime":"0","endTime":"0","summary":"三年间，公司累计亏损超23亿元。目前，艾美疫苗的收入主要来源于其核心产品乙肝疫苗和狂犬病疫苗，其中狂犬病疫苗收入占比近六成。证券之星梳理发现，艾美疫苗近年收入下滑的主因之一是其核心产品狂犬病疫苗的收入失速。从短期来看，这些被艾美疫苗寄予厚望的狂犬疫苗产品无法做出收入贡献。另外，复星国际证券在研报中指出，艾美疫苗的13价肺炎疫苗和23价肺炎疫苗预计分别为2025年和2026年获批。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310105152963f9532&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310105152963f9532&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2518258529","title":"深交所发布关于深港通下的港股通标的证券名单调整的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2518258529","media":"深交所网站","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518258529?lang=zh_cn&edition=full","pubTime":"2025-03-10 08:58","pubTimestamp":1741568314,"startTime":"0","endTime":"0","summary":"因恒生综合大型股指数、中型股指数、小型股指数实施成份股定期调整,根据《深圳证券交易所深港通业务实施办法》的有关规定，港股通标的证券名单发生调整并自2025年03月10日起生效，相关调整信息如下：","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310085053a269149e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310085053a269149e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02407","02423","02431","03669","00697","09869","02461","02522","02799","00743","02410","01541","02582","00999","02510","HSCEI","09959","09966","01119","02587","BK1582","03939","02570","02507","00308","01799","06660","02506","02487","01468","02577","06623","02411","09985","BK1240","01268","06639","06698","00410","03650","02562","02432","02121","02678","02150","02171","01942","00095","00041","01600","02586","HSTECH","02232","BK1555","02460","00659","01318","03309","02105"],"gpt_icon":0},{"id":"2518258503","title":"艾美(6660.HK)重磅大单品人二倍体狂犬疫苗获批临床，效价远高于已上市的人二倍体狂苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2518258503","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518258503?lang=zh_cn&edition=full","pubTime":"2025-03-10 08:29","pubTimestamp":1741566553,"startTime":"0","endTime":"0","summary":"疫苗头部企业艾美疫苗3月9日公告，其研发的迭代工艺高效价人二倍体狂犬疫苗已于近日获得国家药品监督管理局《药物临床试验批准通知书》。该产品是一款迭代升级的人二倍体狂犬疫苗，具有超高效价的明显特点，也是全球狂犬疫苗技术领域的一次重大迭代升级。动物试验表明，免疫后可产生高保护水平的抗体，在同一剂量条件下，这款产品显著高于已上市的人二倍体狂犬疫苗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031008332098a1d842&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031008332098a1d842&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2518020034","title":"艾美疫苗人二倍体狂犬疫苗获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2518020034","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518020034?lang=zh_cn&edition=full","pubTime":"2025-03-09 19:43","pubTimestamp":1741520585,"startTime":"0","endTime":"0","summary":"3月9日，艾美疫苗（06660）发布公告，宣布其研发的人二倍体狂犬疫苗已获得国家药品监督管理局的《药物临床试验批准通知书》。该疫苗是一款迭代升级的高效价产品，具有明显的超高效价特性，动物试验显示其免疫后可产生高保护水平的抗体，效价显著高于市场上已上市的人二倍体狂犬疫苗。此次疫苗的研发突破了传统工艺中的技术瓶颈，优化了纯化工艺，提高了产品质量和安全性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503093340521315.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03347","06660","BK1161","BK1583","BK1141","BK1576"],"gpt_icon":0},{"id":"2517105667","title":"艾美疫苗03月07日遭主力抛售458万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517105667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517105667?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:15","pubTimestamp":1741335309,"startTime":"0","endTime":"0","summary":"03月07日, 艾美疫苗股价跌5.09%，报收5.03元，成交金额8126万元，换手率3.15%，振幅6.23%，量比1.61。艾美疫苗今日主力资金净流出458万元，上一交易日主力净流出795万元。该股近5个交易日下跌11.36%，主力资金累计净流出1190万元；近20日主力资金累计净流出2228万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307165757a263dad0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307165757a263dad0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2517312809","title":"艾美疫苗盘中异动 股价大跌5.09%报5.030港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517312809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517312809?lang=zh_cn&edition=full","pubTime":"2025-03-07 11:35","pubTimestamp":1741318522,"startTime":"0","endTime":"0","summary":"2025年03月07日临近午盘11时35分，艾美疫苗股票出现异动，股价快速跳水5.09%。截至发稿，该股报5.030港元/股，成交量729.98万股，换手率1.44%，振幅4.91%。资金方面，该股资金流入715.89万港元，流出2145.55万港元。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。艾美疫苗股票所在的药品行业中，整体涨幅为0.05%。该公司的产品主要用于治疗乙肝、甲肝、腮腺炎、肾综合征出血热、狂犬病和脑膜炎球菌病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307113522abec49a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307113522abec49a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2517703110","title":"艾美疫苗根据配售协议发行1550万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2517703110","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517703110?lang=zh_cn&edition=full","pubTime":"2025-03-07 08:14","pubTimestamp":1741306440,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　艾美疫苗（06660）发布公告，根据日期为2025年2月28日的配售协议，根据一般授权，于2025年3月6日发行本公司1550万股H股。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-03-07/doc-inenuqsv0155372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2517150983","title":"艾美疫苗(06660)根据配售协议发行1550万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2517150983","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517150983?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:43","pubTimestamp":1741268627,"startTime":"0","endTime":"0","summary":"智通财经APP讯，艾美疫苗(06660)发布公告，根据日期为2025年2月28日的配售协议，根据一般授权，于2025年3月6日发行本公司1550万股H股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258801.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2517864139","title":"艾美疫苗03月06日主力净流出795万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2517864139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517864139?lang=zh_cn&edition=full","pubTime":"2025-03-06 16:17","pubTimestamp":1741249065,"startTime":"0","endTime":"0","summary":"03月06日, 艾美疫苗股价跌0.93%，报收5.30元，成交金额6403万元，换手率2.43%，振幅3.36%，量比0.84。艾美疫苗今日主力资金净流出795万元，上一交易日主力净流入44万元。该股近5个交易日下跌15.50%，主力资金累计净流出943万元；近20日主力资金累计净流出2666万元，其中净流出天数为12日。该股主力净额占比0.30%，港股市场排名2640/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306170519a2622e7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306170519a2622e7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2517189895","title":"艾美疫苗三年亏损超23亿，核心产品狂犬疫苗收入失速，高端疫苗如何突围竞品围剿？","url":"https://stock-news.laohu8.com/highlight/detail?id=2517189895","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517189895?lang=zh_cn&edition=full","pubTime":"2025-03-06 15:00","pubTimestamp":1741244456,"startTime":"0","endTime":"0","summary":"三年间，公司累计亏损超23亿元。目前，艾美疫苗的收入主要来源于其核心产品乙肝疫苗和狂犬病疫苗，其中狂犬病疫苗收入占比近六成。证券之星梳理发现，艾美疫苗近年收入下滑的主因之一是其核心产品狂犬病疫苗的收入失速。根据艾美疫苗的解释，受疫情影响，公司人用狂犬病疫苗的销量及销售收入自截至2021年4月30日至2022年同期分别下降了42.2%和41.7%。从短期来看，这些被艾美疫苗寄予厚望的狂犬疫苗产品无法做出收入贡献。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025030600020097.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","06660","159646"],"gpt_icon":0},{"id":"2517928362","title":"格隆汇沽空预警榜 | 3月4日","url":"https://stock-news.laohu8.com/highlight/detail?id=2517928362","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517928362?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:15","pubTimestamp":1741198500,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日大市沽空比例为18.62%，过去两个月大市日均沽空比例为17.31%。其中，GX中国云算-U、易方达白酒-R、PP美国库A-U沽空比率排名前三位，分别为100.00%、100.00%、100.00%。比亚迪股份、阿里巴巴-W、小米集团-W的沽空金额排名前三位，分别为89.96亿、42.89亿、31.53亿。宜搜科技、汽车街、宜明昂科-B的偏离值排名前三位，分别为18.18、12.19、8.00。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/06021548550907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09826","LU0873338254.USD","06660","02443","XIACY","HTCD.SI","02800","02828","09829","89988","81211","01211","03133","02232","HBBD.SI","HXXD.SI","HYDD.SI","80700","03077","02550","09806","83053","LU0737861699.HKD","01541","03958","03189","83189","81810","002594","09078","BYDDY","03153","01698","IE0032431581.USD","09817","BABA","03033","00290","09988","LU0588545904.SGD","BK1193","01810","00071","08083"],"gpt_icon":1},{"id":"2517995439","title":"艾美疫苗03月05日主力净流入44万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517995439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517995439?lang=zh_cn&edition=full","pubTime":"2025-03-05 16:16","pubTimestamp":1741162577,"startTime":"0","endTime":"0","summary":"03月05日, 艾美疫苗股价涨1.33%，报收5.35元，成交金额3531万元，换手率1.35%，振幅2.84%，量比0.45。艾美疫苗今日主力资金净流入44万元，上一交易日主力净流出134万元。该股近5个交易日下跌4.63%，主力资金累计净流入483万元；近20日主力资金累计净流出2020万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170242abe943cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170242abe943cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2516625278","title":"艾美疫苗03月04日主力净流出134万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2516625278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516625278?lang=zh_cn&edition=full","pubTime":"2025-03-04 17:39","pubTimestamp":1741081184,"startTime":"0","endTime":"0","summary":"03月04日, 艾美疫苗股价跌3.65%，报收5.28元，成交金额2948万元，换手率1.12%，振幅4.93%，量比0.36。艾美疫苗今日主力资金净流出134万元，上一交易日主力净流入151万元。该股近5个交易日下跌3.44%，主力资金累计净流入384万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出2312万元，其中净流出天数为13日。该股主力净额占比0.05%，港股市场排名2563/2648。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174937a25ea79a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174937a25ea79a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2516378690","title":"创新与全球化双轮驱动，艾美疫苗价值重估在即","url":"https://stock-news.laohu8.com/highlight/detail?id=2516378690","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516378690?lang=zh_cn&edition=full","pubTime":"2025-03-04 10:29","pubTimestamp":1741055351,"startTime":"0","endTime":"0","summary":"近日，艾美疫苗（06660.HK）接连发布了两项重要公告，标志着公司在技术创新和全球化布局方面取得了显著进展。首先，公司宣布接入DeepSeek技术平台，积极响应国家“AI+”产业发展战略，全面部署接入DeepSeek大模型，通过本地化策略，推动DeepSeekR1版本在集团全业务场景应用，实现疫苗全生命周期的“降本、提质、增效”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503043335797484.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2514670853","title":"港股药品股盘中下跌，艾美疫苗跌超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514670853","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514670853?lang=zh_cn&edition=full","pubTime":"2025-02-28 10:50","pubTimestamp":1740711043,"startTime":"0","endTime":"0","summary":"南方财经2月28日电，港股药品股盘中下跌，艾美疫苗(06660.HK)跌超11%，腾盛博药(02137.HK)跌超9.5%，乐普生物(02157.HK)、微创机器人(02252.HK)、科笛(02487.HK)均跌超8%，药明巨诺(02126.HK)、德琪医药(06996.HK)均跌超5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202502283332857376.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HSCEI","YANG","BK1161","HSTECH","06660"],"gpt_icon":0},{"id":"2514690133","title":"艾美疫苗股价涨超11%，业绩连续亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2514690133","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514690133?lang=zh_cn&edition=full","pubTime":"2025-02-28 09:54","pubTimestamp":1740707640,"startTime":"0","endTime":"0","summary":"2月27日，艾美疫苗股价跳空高开3个百分点，盘中最大涨幅13.19%，收盘上涨11.59%，报6.26港元，成交金额2.02亿港元。消息面上，艾美疫苗2月26日晚间公告称，公司mRNA呼吸道合胞病毒疫苗已于近日获得美国食品和药品监督管理局临床试验许可。2024年上半年，艾美疫苗实现营业收入5.37亿元，同比下降0.61%，净利润亏损1.39亿元。艾美疫苗正在筹划A股上市。艾美疫苗成立于2011年，2022年10月6日在港交所上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280955119633437d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280955119633437d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2514311369","title":"艾美疫苗拟配售1550万股新H股 预计募资约7770万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514311369","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514311369?lang=zh_cn&edition=full","pubTime":"2025-02-28 09:42","pubTimestamp":1740706941,"startTime":"0","endTime":"0","summary":"2月28日，艾美疫苗（06660）发布公告，宣布与配售代理签订配售协议，计划按每股5.01港元的价格配售1550万股新H股。该配售股份相当于公告日期现有已发行H股股份数目的约3.15%及现有已发行股份数目的约1.28%。假设所有配售股份顺利配售，预计配售事项所得款项总额约为7770万元，扣除相关成本后的净额约为7470万元，净发行价约为每股4.82港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502283332677391.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2514363896","title":"【港股通】艾美疫苗(06660)折让近20%配股 净筹7470万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514363896","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514363896?lang=zh_cn&edition=full","pubTime":"2025-02-28 08:57","pubTimestamp":1740704261,"startTime":"0","endTime":"0","summary":"金吾财讯 | 艾美疫苗(06660)公布，拟配售1550万股新H股予投资经理FMF，占扩大后的已发行H股股份数目的约3.05%及已发行股份数目的约1.26%。每股配售价5.01港元，较上交易日收市价6.26港元折让19.97%。配售事项集资7770万港元，净额7470万港元，拟将净额约60%用于加速公司多个产品线中各项临床前及临床项目的研发，包括开展多区域临床试验，以及用于建设基础设施和相关设施；约20%用于公司新产品的研发、营销及商业化；及约20%用于营运资金及其他企业用途。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/M2UyZGNiNDRjZmIyOTFjZmIzN2JhMmQ2MDYyMzM5MDkyOTMyMQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/M2UyZGNiNDRjZmIyOTFjZmIzN2JhMmQ2MDYyMzM5MDkyOTMyMQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954066","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06660","BK1161","HSCEI","HSTECH","YANG"],"gpt_icon":0},{"id":"2514822357","title":"艾美疫苗拟向FMF配售1550万股配售股份 净筹约7470万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514822357","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514822357?lang=zh_cn&edition=full","pubTime":"2025-02-28 07:54","pubTimestamp":1740700440,"startTime":"0","endTime":"0","summary":"　　艾美疫苗公布，于2025年2月28日，公司与配售代理订立配售协议，拟透过配售代理配售1550万股配售股份，每股配售股份5.01港元。　　假设所有配售股份获悉数配售及待完成后，配售净筹约7470万港元，约60%用于加速公司多个产品线中各项临床前及临床项目的研发，包括但不限于开展多区域临床试验，以及用于建设基础设施和相关设施；约20%用于公司新产品的研发、营销及商业化；约20%用于营运资金及其他企业用途。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-28/doc-inemysvr7276063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06660","BK1161","FMF"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aimbio.com","stockEarnings":[{"period":"1week","weight":-0.3132},{"period":"1month","weight":-0.3382},{"period":"3month","weight":-0.446},{"period":"6month","weight":-0.1208},{"period":"1year","weight":-0.5566},{"period":"ytd","weight":-0.4072}],"compareEarnings":[{"period":"1week","weight":-0.0372},{"period":"1month","weight":0.1018},{"period":"3month","weight":0.1748},{"period":"6month","weight":0.3508},{"period":"1year","weight":0.3735},{"period":"ytd","weight":0.1696}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"艾美疫苗股份有限公司是一家主要从事疫苗研发、制造和销售的中国公司。该公司已商业化产品主要包括重组乙型肝炎疫苗、冻干人用狂犬病疫苗、甲型肝炎灭活疫苗、腮腺炎疫苗、双价肾综合征出血热灭活疫苗以及A、C、Y及W135群脑膜炎球菌多糖疫苗。该公司的在研疫苗产品包括13价肺炎结合疫苗、24价肺炎结合疫苗、四价MDCK细胞流感病毒疫苗、无血清迭代狂犬病疫苗、mRNA带状疱疹疫苗、mRNA迭代狂犬病疫苗、mRNA呼吸道合胞病毒RSV疫苗、新型工艺高效价人二倍体狂犬病疫苗等。","exchange":"SEHK","name":"艾美疫苗","nameEN":"AIM VACCINE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.7","shortVersion":"4.31.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾美疫苗(06660)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾美疫苗(06660)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾美疫苗,06660,艾美疫苗股票,艾美疫苗股票老虎,艾美疫苗股票老虎国际,艾美疫苗行情,艾美疫苗股票行情,艾美疫苗股价,艾美疫苗股市,艾美疫苗股票价格,艾美疫苗股票交易,艾美疫苗股票购买,艾美疫苗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾美疫苗(06660)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾美疫苗(06660)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}